Hong Kong's Hospital Authority negotiates lower prices for medication as part of cost-cutting measures
Hospital Authority chief executive Tony Ko said on Wednesday that, of the pharmaceutical firms it had spoken with – most of which make drugs for cancer and chronic conditions – around 70 per cent agreed to lower prices. The average price cut was about 20 per cent.
The Hospital Authority is also planning to rely more on generic drugs instead of brand-name medication, Ko said, citing expiring patents on some drugs paving the way for other manufacturers.
William Chui, the Hospital Authority's chief pharmacist, said that market competition could lower prices across the board.
'Whether it's generic drugs manufactured in India, Western countries or mainland China, the original manufacturers will follow by reducing their prices,' Chui said in Cantonese.
Last year, the Hospital Authority established a 'Cost Assessment Panel' to negotiate costs with pharmaceutical firms.
In March, the Health Bureau said it had reduced procurement costs for some drugs for colon cancer and paroxysmal nocturnal haemoglobinuria, a type of rare blood disorder.
The Hospital Authority will continue to promote the 'diversification of drug supply so as to provide patients with safe, efficacious and cost-effective drugs,' the bureau added.
On Wednesday, Chui said authorities had taken reference from drug prices offered under mainland China's medical insurance system while negotiating costs. The Hospital Authority is also looking to purchase medical equipment from mainland China, he said.
Ko added on Wednesday that the Hospital Authority has been using artificial intelligence (AI) to draft medical reports since March. Around 80 per cent of reports can be processed by AI, he said, helping save about 40 per cent of the time staff spend handling paperwork.
Lowered drug costs at public hospitals come as the city is set to raise fees for services such as non-critical Accident and Emergency (A&E) room visits.
The hike is part of a reform that Secretary for Health Lo Chung-mau called 'belated and necessary,' saying that the current public healthcare system, which is heavily subsidised by the government, is not sustainable.
Under the new plan, patients classified as 'urgent,' 'semi-urgent,' or 'non-urgent' will have to pay HK$400 for A&E services. The current fee has been HK$180 since 2017.
Patients classified as 'critical,' referring to those who should receive immediate medical attention and those classified as 'emergency,' which should be attended to within 15 minutes, will be treated for free.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
South China Morning Post
6 minutes ago
- South China Morning Post
Cheaper drugs, revamped fees are healthy steps for Hong Kong
The accessible and affordable world-class public health system Hong Kong enjoys – and expects – comes at an ever-increasing price, amid an ageing society and the rising costs of medical and pharmaceutical advances. A revamp of the fee structure from next year, to recover more of the spiralling costs to the government's budget, was inevitable. Rightly, it is subject to measures to safeguard access for the most vulnerable members of society. It is good, therefore, to learn the government is going on the front foot in negotiations with pharmaceutical companies to get the best deals for many of the drugs that public patients need and the best value for the massive public investment in healthcare. As a result, patients can soon expect to pay about 20 per cent less for some drugs. Hospital Authority chief executive Dr Tony Ko Pat-sing anticipates savings to public funds of at least HK$1 billion (US$127 million) from measures including drug price reductions and expansion of sources of supplies. This is thanks in large part to a greater emphasis on a thorough procurement process. The Hospital Authority's chief pharmacist, William Chui Chun-ming, says when hospital drugs are reasonably priced, the authority can use the money saved to buy more new drugs or extend the range in stock. So far, he says, 70 per cent of drug makers, mostly from foreign countries, are willing to give discounts of an average of 20 per cent. The authority's negotiators used as a reference drug prices offered under the mainland's medical insurance system, which are generally lower due to the bargaining power of bulk procurement for a huge population. Beijing said last year that this had saved patients more than 880 billion yuan (US$123 billion). The potential for cost-effective optimisation of access to the latest pharmaceutical drugs will be enhanced by Hong Kong's aspiration to become an international medical and innovation hub, including a recognised clinical drug-trial centre. Chui said the authority would also monitor drugs in phase three clinical trials and approach developers for access to data with a view to adoption in public hospitals soon.
RTHK
2 days ago
- RTHK
HK Disneyland donates for child patients' experiences
HK Disneyland donates for child patients' experiences Tuen Mun Hospital pioneered the initiative in early July with immersive Disney murals and a mobile movie theatre. Photo courtesy of Hong Kong Disneyland Hong Kong Disneyland has pledged over HK$5 million to support young patients and youth development initiatives across the city. More than half of the proceeds will fund the transformation of certain areas in eight public hospitals, while the remainder supports broader youth development programmes. At Tuen Mun Hospital, a beneficiary, Managing Director Michael Moriarty said on Saturday the multi-phase project would elevate the in-hospital experience for child patients. Tuen Mun Hospital pioneered the initiative in early July with immersive Disney murals and a mobile movie theatre. "This marks a meaningful new chapter in our journey, growing our legacy of care, bringing comfort to young patients and creating moments of joy where they're needed the most," Moriarty said. "I'd like to thank the committed staff here at Tuen Mun Hospital, our passionate volunteers and cast members, and everyone who supports being behind the scenes to make a dream like this come true." "Every small act counts and when you see the smiles on the faces of these children it's worth all the effort that goes into bringing these ideas to life." Hospital Authority Chairman Henry Fan highlighted the initiative's alignment with patient-centred care, stating that the revitalised environments would ease anxiety for young patients and their families during waiting times, enhancing their overall experience. The impact resonated with 12-year-old anemia patient, An Yu, who expressed excitement after seeing the brand-new hospital environment for the first time. "I visited the hospital every few months for follow-up since I was a child. I used to be nervous while waiting. The refurbished waiting area is now totally different. The whole place is so colourful with murals of many Disney characters. It made me so happy and relaxed," she said.
RTHK
2 days ago
- RTHK
Tech and talent key to future of public hospitals: Ko
Tech and talent key to future of public hospitals: Ko Tony Ko says digital transformation will remain central to tackling rising healthcare demands. Photo: RTHK Outgoing Hospital Authority Chief Executive Tony Ko says new technology and a skilled workforce are key to the future of the public health system, as he reflected on his six years in the job. Ko was speaking to the media ahead of the end of his tenure on July 31, when he will be replaced by former Under Secretary for Health Libby Lee Ko said that advancing healthcare technology -- through initiatives like telehealth, Smart Hospital 2.0 and the clinical management system – was vital to better patient care and clinical service quality. He also said a few large projects were set to come onstream. "We have a few hospital projects already in place now, say the new Kwong Wah Hospital... and we have more projects coming up. We will soon have the new clinical blocks of Queen Mary Hospital and all the other things," he said. Ko said medical personnel had grown by over 10 percent and that more than 300 non-locally trained doctors were now serving in public hospitals. "We noticed that our manpower situation has actually much improved when compared to six years ago. "Not only we have a much lower attrition rate now, but also we are able to attract talent from different parts of the world, from overseas, from the mainland, literally making Hong Kong become an international medical talent hub." Ko, a geriatrician who steered the authority through the Covid outbreak, said Hong Kong has now faced two major pandemics - if the 2003 Sars outbreak is also included - and that that the authority is now well-prepared for any that may occur in future. After over 30 years' experience in the public health system, Ko described his role as fulfilling and rewarding. He said he now aims to pursue further education, possibly in history or music.
